Amount of Opioids Prescribed After Hospital Discharge Varies

Share this content:
Amount of Opioids Prescribed After Hospital Discharge Varies
Amount of Opioids Prescribed After Hospital Discharge Varies

WEDNESDAY, Dec. 13, 2017 (HealthDay News) -- For postoperative patients there is considerable variation in the amount of opioids prescribed at hospital discharge, according to research published online Dec. 13 in JAMA Surgery.

Eric Y. Chen, M.D., Ph.D., from Boston Medical Center, and colleagues conducted a retrospective record review of 18,343 postoperative patients who were discharged home after a postoperative inpatient admission of at least 24 hours.

The researchers found that given a postoperative patient's 24-hour predischarge opioid use, there was wide variation in the amount of opioids prescribed at hospital discharge. Overall, 35.7 percent of patients used no opioids in the 24 hours before discharge; 45.6 percent of these patients were prescribed opioids at hospital discharge. The services with the highest rates of potential over-prescription tended to have the highest rates of patients still using opioids at hospital discharge (obstetrics [adjusted odds ratio, 3.146; 95 percent confidence interval, 2.094 to 4.765], gynecology [adjusted odds ratio, 2.355; 95 percent confidence interval, 1.663 to 3.390], orthopedics [adjusted odds ratio, 0.943; 95 percent confidence interval, 0.719 to 1.242], and plastic surgery [adjusted odds ratio, 0.733; 95 percent confidence interval, 0.334 to 1.682]). The only service that did not have any cases of potential over-prescription was pediatric surgery.

"Opioids are not regularly prescribed in a patient-specific manner to postoperative patients," the authors write. "Potential opioid over-prescription occurs regularly after surgery among almost all surgical specialties."

One author disclosed financial ties to Smith & Nephew and Exploramed.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »